Overview
Updated 14 Jul 2026
Richard Ambinder, MD, is James B. Murphy Professor of Oncology at Johns Hopkins University School of Medicine / Sidney Kimmel Comprehensive Cancer Center. The public record shows 627 publications with 25,685 citations (h-index 88), centered on Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation. It also documents an investigator role on 11 registered clinical trials, 19 NIH-funded awards (1985–2026).
- Most recent indexed publication: 2026 · Blood
- Top research focus: Viral-associated cancers and disorders
- 11 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 296.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Sponsor: AIDS Malignancy Consortium
InvestigatorRecruitingNCT05663502 - Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)
Sponsor: Catherine Bollard
InvestigatorPhase 1Active, not recruitingNCT04248192 - A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Sponsor: AIDS Malignancy Consortium
InvestigatorEarly phase 1RecruitingNCT04139304
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 14 Jul 2026
19 NIH research awards on record, funded 1985–2026 per NIH RePORTER. The latest:
- Enrichment for Tumor-derived Cell-free EBV DNA: Towards a Diagnostic Assay for Endemic Burkitt Lymphoma
Johns Hopkins University
FY2026$259,527U01CA271252 - Enrichment for Tumor-derived Cell-free EBV DNA: Towards a Diagnostic Assay for Endemic Burkitt Lymphoma
Johns Hopkins University
FY2026$65,268U01CA271252 - Investigating the EBV methylome in PLWH: Discovery and Development of Novel EBV Diagnostics in Plasma and Saliva
Johns Hopkins University
FY2025$667,061U01CA284811
Congress activity
Updated 14 Jul 2026
46 congress contributions (2006–2025) across AACR, ASCO, ASH, ESMO per OpenAlex. The most recent:
- Real world safety outcomes of an outpatient lymphoma bispecific antibody program: A single center experience from Johns Hopkins.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited worksby citation count (OpenAlex)
- 01
- 02
- 03
- 04
- 05Hodgkin lymphoma: A review and update on recent progress482 citations2017
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
401 North Broadway Street, Weinberg Building, Baltimore, MD 21287
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- M.D.
Johns Hopkins University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗ - Ph.D. in Pharmacology
Johns Hopkins University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗ - B.A. in Biochemistry
Harvard College
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopkinsmedicine.org ↗
Editorial & leadership rolesjournal and society appointments
- Program Co-Leader
Hematologic Malignancies and Bone Marrow Transplantation Program, Johns Hopkins Kimmel Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗ - Site Leader
AIDS Malignancy Consortium (AMC) at Johns Hopkins
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗ - National Lead
AMC Translational Sciences Working Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopkinsmedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/richard-ambinder-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harry Quigley, MD
Johns Hopkins University
- 623
- publications
- 106
- h-index
- 4
- trials
Constantine Lyketsos, MD
Johns Hopkins University
- 763
- publications
- 105
- h-index
- 5
- trials
Robert Wise, MD
Johns Hopkins University
- 1,364
- publications
- 124
- h-index
- 11
- trials
Michael Carducci, MD
Johns Hopkins University
- 1,096
- publications
- 104
- h-index
- 20
- trials